LATS2 and melanoma: Consistent with these findings, our study identified LATS2 as a direct target of miR-424-5p, and its silencing reversed the inhibitory effects of miR-424-5p inhibition on HUVEC functions, suggesting that the exosomal miR-424-5p/LATS2 axis contributes to melanoma progression by promoting angiogenesis.